ClinicalTrials.gg
RecruitingNCT05264857Updated Oct 14, 2025

Decision Aid and Thyroid Nodules Management

An interventional study of Thyroid Nodule Management Education in Thyroid Nodule, sponsored by Stony Brook University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-14.

Sponsored by Stony Brook University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Feb 2022; still recruiting 4 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
134
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Patients with small favorable malignant or indeterminate thyroid nodules will receive information about management of thyroid nodules. Participants will be asked to complete brief surveys at the time of enrollment, shortly after the consultation appointment with the surgeon, and a few months after either the consultation or the surgery, to assess their satisfaction with their decision and decision making process. All participants will receive routine care and counseling by their endocrinologist and surgeon.

02

Conditions studied

  • Thyroid Nodule

Browse trials for

03

In context

Thyroid Nodule

207 studies on the registry are indexed under Thyroid Nodule; 64 are open to participants now.

This study's planned enrollment of 134 is above the median of 75 across 121 interventional studies indexed under Thyroid Nodule.

Browse Thyroid Nodule studies →

Lead sponsor

Stony Brook University is the lead sponsor of 197 studies on the registry; 36 are open to participants now.

Of its 23 completed or terminated interventional studies of FDA-regulated products, 11 (48%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Histology showing indeterminate or malignant thyroid pathology (Bethesda III-VI)
  • Thyroid nodule size less or equal to 2cm

Exclusion criteria

Exclusion Criteria:

  • History of thyroid surgery
  • History of thyroid cancer
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
134 participants (estimated)

Study arms

  • Experimental
    Thyroid nodule information

    Behavioral: Thyroid Nodule Management Education

Interventions

  • BehavioralThyroid Nodule Management Education

    Participants will receive information about thyroid nodules and their management

06

What researchers measure

Primary outcomes

  1. Rate of congruence between informed values and treatment choice

    Percent of patients with congruence between treatment option and informed values based on a survey

    Time frame: 6 months from surgery or surgical consultation date

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05264857
Responsible party
Lukasz Czerwonka (Head and Neck Surgeon, Stony Brook University) — Principal investigator
First posted
Mar 3, 2022
Start date
Feb 8, 2022
Primary completion
Sep 30, 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Oct 14, 2025

Study contacts

Jessica Alfano
Contact
jessica.alfano@stonybrookmedicine.edu
631-216-2993
Caterina Vacchi-Suzzi
Contact
caterina.vacchi-suzzi@stonybrookmedicine.edu
631-216-2993
Lukasz Czerwonka, MD
principal investigator · Lukasz.Czerwonka@stonybrookmedicine.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion